Performance of Remsima® Monitor Drug Level versus RIDASCREEN IFX Monitoring in therapeutic drug monitoring of infliximab in patients with inflammatory bowel disease: A study of diagnostic accuracy

Therapeutic drug monitoring (TDM) is effective in optimizing the efficacy of infliximab in patients with inflammatory bowel disease (IBD). An affordable way of monitoring is in high demand. This study evaluated the analytical and clinical performances of the newly available Remsima monitor kits and...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Joo Hye, Hong, Sung Noh, Kim, Eun Ran, Chang, Dong Kyung, Kim, Young-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509095/
https://www.ncbi.nlm.nih.gov/pubmed/36197194
http://dx.doi.org/10.1097/MD.0000000000030683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509095/
https://www.ncbi.nlm.nih.gov/pubmed/36197194
http://dx.doi.org/10.1097/MD.0000000000030683

Ejemplares similares